M T Bertero
Overview
Explore the profile of M T Bertero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montaruli B, De Luna E, Erroi L, Marchese C, Mengozzi G, Napoli P, et al.
Int J Lab Hematol
. 2016 Feb;
38(2):172-82.
PMID: 26847159
Introduction: We evaluated analytical and clinical performances of IgG and IgM anticardiolipin (aCL) antibodies and anti-β2-glycoprotein I (a-β2GpI) antibodies and upper limit reference ranges (99th percentiles) in comparison with manufacturer's...
2.
Bazzan M, Vaccarino A, Stella S, Sciascia S, Montaruli B, Bertero M, et al.
Lupus
. 2015 Dec;
25(5):479-85.
PMID: 26657216
Background: Patients with antiphospholipid syndrome (APS) often have thrombotic recurrences, sometimes despite appropriate ongoing anticoagulant treatment. Identifying APS vascular patients at high risk for thrombotic recurrences is still an unsolved...
3.
Bazzan M, Vaccarino A, Stella S, Bertero M, Carignola R, Montaruli B, et al.
Autoimmun Rev
. 2012 Dec;
12(8):826-31.
PMID: 23219773
In APS vascular patients, thrombotic recurrences are more frequent than in non-APS thrombotic patients. To better define this clinical setting, a systematic review of the literature after 1999 was performed:...
4.
Bertero M, Bazzan M, Carignola R, Montaruli B, Silvestro E, Sciascia S, et al.
Lupus
. 2012 May;
21(7):806-9.
PMID: 22635240
We report the experience from the Antiphospholipid Antibodies (aPL) Regional Consortium in northwest Italy, meant to support clinical research and foster collaboration among health professionals regarding the diagnosis and management...
5.
Montaruli B, De Luna E, Mengozzi G, Molinari F, Napolitano E, Napoli P, et al.
Lupus
. 2012 May;
21(7):799-801.
PMID: 22635238
Laboratory tests for anticardiolipin antibodies (aCL) and anti-β2glycoprotein I antibodies (a-β2GPI) face problems common to many autoantibody assays: the lack of a reference standard and the need for each laboratory...
6.
Bertero M
Lupus
. 2012 May;
21(7):751-4.
PMID: 22635222
The discovery of antiphospholipid antibodies (aPL) positivity in individuals who have never experienced thrombosis or pregnancy complications is not a rare event, and is one of the unresolved issues in...
7.
Pisoni C, Brucato A, Ruffatti A, Espinosa G, Cervera R, Belmonte-Serrano M, et al.
Arthritis Rheum
. 2010 Feb;
62(4):1147-52.
PMID: 20131278
Objective: Congenital heart block (CHB) is presumed to be caused by transplacental passage of maternal immunoglobulin against Ro and La ribonucleoproteins. The recurrence rate in subsequent pregnancies following the birth...
8.
Demaestri M, Sciascia S, Kuzenko A, Bergia R, Barberis L, Lanza M, et al.
Lupus
. 2009 Mar;
18(4):368-71.
PMID: 19276307
Pregnancy in patients suffering from undifferentiated connective tissue disease (UCTD) represents a risk situation for both the mother and the child. SSA/SSB autoantibodies can determine neonatal lupus (NL) in the...
9.
Ruffatti A, Del Ross T, Ciprian M, Nuzzo M, Rampudda M, Bertero M, et al.
Ann Rheum Dis
. 2008 Sep;
68(3):397-9.
PMID: 18812393
Objectives: To asses risk factors for a first thrombotic event in antiphospholipid antibody (aPL) positive carriers and evaluate the efficacy of prophylactic treatments. Methods: Recruitment criteria were age 18-65 years,...
10.
Fracchia M, Galatola G, Corradi F, DallOmo A, Rovera L, Pera A, et al.
Dig Liver Dis
. 2004 Aug;
36(7):489-91.
PMID: 15285530
Although coeliac disease may occur in patients affected by another immune-mediated disorder, its coexistence with multiple autoimmune diseases is not frequently described. We report here the case of a 45-year-old...